We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

Fund managers haven’t disclosed any holdings of GHDX yet.

GHDX Hedge Fund Activity: Q2 2020 in Review

0 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q2 2020, worth a combined $0 — down 100% from $1K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of GHDX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Filbrandt Wealth Management, exiting entirely with an estimated $1K sold.

  • 0 institutional investors held Genomic Health, Inc. (GHDX) as of Q2 2020, down from 1 in Q1 2020.
  • Funds reported $0 of Genomic Health, Inc. stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Genomic Health, Inc. positions in Q2 2020 and 1 closed out, a net change of -1 holder.
  • The largest Genomic Health, Inc. seller in Q2 2020 was Filbrandt Wealth Management, an estimated $1K sold.

Based on aggregated 13F filings for Q2 2020.